H.C. Wainwright Keeps Their Buy Rating on Motif Bio plc

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Motif Bio plc (NASDAQ: MTFB) today and set a price target of $32. The company’s shares closed on Friday at $8.72.

Selvaraju observed:

“We reiterate our Buy rating and 12-month target of $32.00 per share on MTFB.”

According to TipRanks.com, Selvaraju is a 3-star analyst with an average return of 1.7% and a 41.8% success rate. Selvaraju covers the Healthcare sector, focusing on stocks such as IntelliPharmaCeutics International, Biospecifics Technologies Corp, and EyePoint Pharmaceuticals Inc.

Motif Bio plc has an analyst consensus of Moderate Buy, with a price target consensus of $28.50.

See today’s analyst top recommended stocks >>

The company has a one-year high of $13.75 and a one-year low of $6.84. Currently, Motif Bio plc has an average volume of 2,640.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Motif Bio Plc is a clinical stage biopharmaceutical company which develops novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. It pipeline of antibiotics includes iclaprim, and MTF-001, a preclinical program to design a dihydrofolate reductase inhibitor (DHFRi).